Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8309361 | 0.80 | — | — | |
| SCHEMBL1921383 | 0.80 | TSHR (0.33) | TSHR | |
| SCHEMBL1921620 | 0.78 | LMNA (0.32) | — | |
| SCHEMBL8434068 | 0.75 | OPRM1 (0.38) | — | |
| SCHEMBL13980428 | 0.73 | — | — | |
| SCHEMBL3977096 | 0.72 | — | — | |
| SCHEMBL1922947 | 0.72 | TSHR (0.31) | TSHR | |
| SCHEMBL1888949 | 0.70 | — | — | |
| SCHEMBL503862 | 0.70 | — | — | |
| SCHEMBL2352756 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2330675-B1 | SECONDARY BATTERY | NEC CORP (JP) | 2018-08-22 | — | — | EP | disclosed |
| US-20120171542-A1 | SECONDARY BATTERY | NEC CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| EP-2384331-A1 | MIXED GLYCOL POLYPHOSPHONATE COMPOUNDS | Albemarle Corporation (US) | 2011-11-09 | — | — | EP | disclosed |
| US-20110218260-A1 | Mixed Glycol Polyphosphonate Compounds | ALBEMARLE CORPORATION (US) | 2011-09-08 | — | — | US | disclosed |
| US-20110159379-A1 | SECONDARY BATTERY | NEC CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-2330675-A1 | SECONDARY BATTERY | NEC Corporation (JP) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010048121-A1 | MIXED GLYCOL POLYPHOSPHONATE COMPOUNDS | ALBEMARLE CORPORATION (US) | 2010-04-29 | — | — | WO | disclosed |
| US-4096192-A | DIOL REACTED WITH ACROLEIN, HYDROFORMYLATION, HYDROGENATION, HYDROLYSIS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4024197-A | 2-VINYL-5-METHYL-1,3-DIOXANE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-3963754-A | 2-Vinyl-5-methyl-1,3-dioxane | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
| US-3963755-A | Mixture of 2(2'-propanal)-5-methyl-1,3-dioxane and 2(3'-propanal)-5-methyl-1,3-dioxane | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218260-A1 | Mixed Glycol Polyphosphonate Compounds | PFAS, FRG1, PCBP1 | TSHR 3875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.